TORONTO, April 26, 2018 (GLOBE NEWSWIRE) -- Knalysis Technologies (“Knalysis”), a subsidiary of Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) is thrilled to announce that we are one of three finalists for the KIRA Award for the Most Innovative Start-Up. The KIRAs celebrate excellence in technological, social and economic innovation across all sectors and industries in New Brunswick.
“This nomination is truly an honour,” says Paul Methot, President of Knalysis Technologies, “Being recognized as an innovator in this emerging medical cannabis market really validates the importance of bringing new technologies to bear to gather critical data with the purpose of improving patient outcomes.”
The winners will be announced at the KIRA Awards on May 3rd as part of New Brunswick’s Innovation Week.
About Knalysis Technologies:
Knalysis Technologies is a wholly owned subsidiary of the Canada House Wellness Group, a publicly traded Canadian company with one of the largest networks of cannabis clinics in Canada. We envisioned a need for health technology connecting every aspect of the medical marijuana field, and pioneered software to seamlessly link physician, provider, and patient. Purpose-built in our own clinics, Knalysis’ suite of software has been battle-tested with thousands of patients for over four years; treating a broad range of ailments and symptoms.
Canada House Wellness Group Inc.
Canada House is the parent company of Marijuana for Trauma Inc., Knalysis Technologies and Abba Medix Corp. The Company’s goal is to become a marketplace leader through strategic partnerships, mergers, and acquisitions to create a fully integrated cannabis therapy company. For more information please visit https://www.canadahouse.ca. or www.sedar.com
Cautionary Statement Regarding Forward‐Looking Information. Certain statements within this news release pertaining to the Company constitute “forward‐looking statements”, within the meaning of applicable securities laws, including without limitation, statements regarding future estimates, business plans and/or objectives, sales programs, forecasts and projections, assumptions, expectations, and/or beliefs of future performance, are “forward‐looking statements”. Such “forward‐looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements. Forward‐looking statements include, but are not limited to, statements with respect to the anticipated effects of the financing, regulatory changes, timeliness of government approvals for the granting of permits and licenses, changes in medical marijuana prices, actual operating performance of facilities, competition and other risks affecting the Company in particular and the medical marijuana industry generally, including those set out in the Company’s public disclosure record. The Company assumes no responsibility to update or revise forward‐looking information to reflect new events or circumstances unless required by law.
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
For further information, please contact:
Boom Capital Markets
Steve Low
647-620-5101
steve@boomcapitalmarkets.com
Canada House Wellness Group, Inc.
Larry Bortles
1-844-696-349
lbortles@canadahouse.ca